Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ALKEM LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ALKEM LABORATORIES DR. DATSONS LABS/
ALKEM LABORATORIES
 
P/E (TTM) x -10.9 25.0 - View Chart
P/BV x 0.2 6.0 2.7% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 DR. DATSONS LABS   ALKEM LABORATORIES
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ALKEM LABORATORIES
Mar-20
DR. DATSONS LABS/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1262,720 4.6%   
Low Rs311,660 1.9%   
Sales per share (Unadj.) Rs133.0697.9 19.1%  
Earnings per share (Unadj.) Rs0.296.1 0.2%  
Cash flow per share (Unadj.) Rs6.6117.3 5.6%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs128.8515.2 25.0%  
Shares outstanding (eoy) m31.66119.57 26.5%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.1 18.7%   
Avg P/E ratio x516.122.8 2,265.1%  
P/CF ratio (eoy) x11.818.7 63.4%  
Price / Book Value ratio x0.64.3 14.3%  
Dividend payout %026.0 0.0%   
Avg Mkt Cap Rs m2,477261,879 0.9%   
No. of employees `000NA14.3 0.0%   
Total wages/salary Rs m5615,055 0.4%   
Avg. sales/employee Rs ThNM5,822.6-  
Avg. wages/employee Rs ThNM1,050.5-  
Avg. net profit/employee Rs ThNM802.0-  
INCOME DATA
Net Sales Rs m4,21183,444 5.0%  
Other income Rs m791,042 7.6%   
Total revenues Rs m4,28984,486 5.1%   
Gross profit Rs m56914,734 3.9%  
Depreciation Rs m2042,528 8.1%   
Interest Rs m430651 66.1%   
Profit before tax Rs m1312,598 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,105 0.6%   
Profit after tax Rs m511,493 0.0%  
Gross profit margin %13.517.7 76.5%  
Effective tax rate %48.08.8 547.7%   
Net profit margin %0.113.8 0.8%  
BALANCE SHEET DATA
Current assets Rs m6,85254,960 12.5%   
Current liabilities Rs m6,71132,433 20.7%   
Net working cap to sales %3.327.0 12.4%  
Current ratio x1.01.7 60.3%  
Inventory Days Days16180 202.2%  
Debtors Days Days31872 441.4%  
Net fixed assets Rs m3,67332,710 11.2%   
Share capital Rs m317239 132.4%   
"Free" reserves Rs m3,76161,368 6.1%   
Net worth Rs m4,07861,607 6.6%   
Long term debt Rs m1,6711,592 104.9%   
Total assets Rs m12,63399,433 12.7%  
Interest coverage x1.020.4 5.1%   
Debt to equity ratio x0.40 1,585.3%  
Sales to assets ratio x0.30.8 39.7%   
Return on assets %3.412.2 28.2%  
Return on equity %0.118.7 0.6%  
Return on capital %7.721.0 36.6%  
Exports to sales %22.919.1 120.0%   
Imports to sales %14.33.0 480.4%   
Exports (fob) Rs m96415,917 6.1%   
Imports (cif) Rs m6022,483 24.2%   
Fx inflow Rs m96416,061 6.0%   
Fx outflow Rs m6072,483 24.5%   
Net fx Rs m35713,578 2.6%   
CASH FLOW
From Operations Rs m1,3455,851 23.0%  
From Investments Rs m-2,256-7,414 30.4%  
From Financial Activity Rs m-1,200792 -151.6%  
Net Cashflow Rs m-2,111-731 288.7%  

Share Holding

Indian Promoters % 4.5 66.9 6.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 33.1 -  
FIIs % 1.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 0.0 -  
Shareholders   20,807 68,381 30.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   DIVIS LABORATORIES  WOCKHARDT  VENUS REMEDIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Momentum Moves: The Week Gone By(Momentum Moves)

Nifty and Sensex ended the week gaining 0.60% and 0.52% respectively. Bulls started the week roaring but since Wednesday, the momentum seemed to be tiring.

Related Views on News

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS